[Effect of yangjing zhongyu decoction on expression of insulin-like growth factor II and its receptor in endometrium of women with unexplained infertility]

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Jul;22(7):490-3.
[Article in Chinese]

Abstract

Objective: To investigate the effect of Yangjing Zhongyu Decoction (YJZYD) on expression of insulin-like growth factor II (IGF-II) and its receptor II (IGF-II R) in endometrium of women with unexplained infertility, and the relationship of which with the receptibility of endometrium to ovum implantation.

Methods: Reverse transcription-polymerase chain reaction (RT-PCR) assay was used to detect quantitatively the expression of IGF-II and IGF-II R in 22 women with unexplained infertility before and after YJZYD treatment during mid-luteal phase.

Results: The levels of IGF-II and IGF-II R before treatment were 0.794 +/- 0.453 and 0.725 +/- 0.354 (in grey level, the same below) respectively, which were significantly increased in the same phase after treatment, reaching 1.202 +/- 0.551 and 1.045 +/- 0.581 respectively (P < 0.01 and P < 0.05). Correlation analysis showed the level of IGF-II mRNA was positively correlated with the level of IGF-II mRNA either before or after treatment.

Conclusion: YJZYD could enhance the expression of IGF-II and IGF-II R in the endometrium during mid-luteal phase, promote the differentiation of endometrium and increase its reception to ovum implantation.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Embryo Implantation / drug effects
  • Endometrium / metabolism*
  • Female
  • Humans
  • Infertility, Female / drug therapy*
  • Infertility, Female / metabolism
  • Insulin-Like Growth Factor II / biosynthesis*
  • Insulin-Like Growth Factor II / genetics
  • Luteal Phase
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Receptor, IGF Type 2 / biosynthesis*
  • Receptor, IGF Type 2 / genetics

Substances

  • RNA, Messenger
  • Receptor, IGF Type 2
  • Insulin-Like Growth Factor II